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Abstract
Before 1990, options were limited for couples who were at risk for transmitting a genetic disease or a structural chromosomal 
abnormality to their children . Couples traditionally underwent invasive procedures such as amniocentesis and chorionic villus sam-
pling, after which termination was offered if the fetus was found to be affected . Many couples chose not to have children at all . 
Since then, technological advances have allowed preimplantation genetic testing (PGT) to be offered to these couples . Couples who 
choose PGT undergo in-vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), where the oocyte is injected by a single 
sperm and is then implanted into the mother a few days later . However, in PGT, a few cells are removed and genetically analyzed 
before implantation to determine whether the embryo has a specific genetic defect or aneuploidy. The purpose of this paper is 
to determine whether PGT causes adverse clinical outcomes by critically analyzing PGT research studies . Current research does 
not seem to show any major adverse clinical outcomes after PGT especially in cases of singleton pregnancies . It is important to 
continue to examine the effects of an embryo biopsy in terms of neonatal and obstetric outcomes, as well as future development .
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Robyn Weiss graduated in June 2020 with a Bachelor of Science degree in Biology and is accepted into the Master 
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Introduction
Preimplantation genetic testing (PGT) has become an 
integral part of assisted reproductive technology (ART) 
and over a third of ART Centers in the United States are 
utilizing PGT technology (Kuliev, Rechitsky, 2017). There 
are three kinds of PGT. The first, PGT-M, analyzes the em-
bryo for monogenic diseases. This is generally used when 
one or both parents carry a mutation, such as those 
linked to Huntington’s disease or cystic fibrosis. Testing is 
performed to ensure the single-gene trait has not been 
passed to the embryo. It is often used after a previous 
child has been diagnosed with a specific genetic condition. 
PGT-M may also be used for sex selection, such as when 
a parent is a carrier of an x-linked disorder (Pastore, et. 
al. 2019). The second, PGT-A, and third, PGT-SR, are not 
standard procedures and were developed to improve the 
success rate of IVF. PGT-A is used to look for embry-
onic aneuploidy and PGT-SR is used to look for chro-
mosomal structural rearrangements such as inversions 
or translocations. PGT-A and PGT-SR are usually only 
recommended in cases of previous failed rounds of IVF, 
severe male infertility, recurrent pregnancy loss, in cases 
where one or both parents have a balanced chromosome 
structural rearrangement, or for patients at high risk for 
embryo aneuploidy, such as those of advanced maternal 
age. While all forms of PGT come with many ethical ques-
tions, in general PGT-M is considered more acceptable, 
especially when it is used to prevent severe genetic dis-
eases with few treatment options. Genetic counseling is 
recommended before any form of PGT to ensure that 
the couple understands the risks and limitations of the 
procedure (Eskew, Jungheim, 2017).
There are multiple methods of performing PGT. Polar 
body biopsy (PBB) is a common method for genetical-
ly analyzing an embryo. Polar bodies are formed during 
meiosis of an oocyte and are not required for fertiliza-
tion or embryo development. Therefore, they can be re-
moved safely and screened without harming the embryo. 
Additionally, PBB avoids errors due to the presence of 
mosaicism that other methods of PGT incur. Mosaicism is 
when different cells have different genotypes within one 
organism and is not present at the zygote stage. PBB is 
considered a less invasive procedure and is a good option 
for patients who view more invasive procedures as un-
ethical. However, PBB can only provide maternal genetic 
information. Because PBB does not include paternal ge-
netic information and cannot be used to determine gen-
der, this method can only work in certain cases (Schenk, 
et. al. 2018).
PGT can also be done through a blastomere biopsy 
during the cleavage stage. This is done three days after 
fertilization, when the embryo is between six to eight 
cells. A blastomere biopsy is an invasive procedure where 
cell-to-cell adhesions are loosened and one or two blas-
tomeres are aspirated. The blastomeres are then genet-
ically analyzed for either aneuploidy or specific genetic 
mutations (Kalma, et. al. 2018). A blastomere biopsy al-
lows both maternal and paternal genetic information to 
be analyzed, which makes determining the gender of the 
embryo possible. However, given that this is an invasive 
procedure, this method may affect the growth and devel-
opment of the embryo. While there is evidence that a day 
three embryo can tolerate and overcome the possible 
resultant damage, it is likely that embryos that would oth-
erwise progress to implantation will be lost at this stage 
of embryo development. Additionally, a blastomere biopsy 
may not always be reliable since it is affected by both the 
technical and biological problems associated with single 
cell analysis. Specifically, mosaicism, which is at the high-
est level at this stage of development, can lead to false 
positive and false negative errors. In order to compen-
sate, two blastomeres can be removed. While this may 
increase the accuracy of the genetic testing, around 25% 
of the embryonic mass is removed, which may impact 
clinical outcomes (Cimadomo, et. al. 2016).
A third method of PGT is a blastocyst biopsy. It is 
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usually done five to six days after fertilization, when the 
embryo is about one hundred cells. During a blastocyst 
biopsy, five to six cells of the trophectoderm are removed 
and analyzed. This method allows more cells to be test-
ed, compared to the only one or two cells that can be 
removed during a blastomere biopsy, and allows for im-
proved accuracy of the genetic testing. Additionally, this 
procedure removes a smaller proportion of embryo cell 
mass when compared to the day three biopsy and only 
removes cells from the trophectoderm, not the inner 
cell mass. However, blastocyst biopsies have limitations 
as well. Only 50% of IVF embryos develop to the blasto-
cyst stage and waiting for a day five biopsy may result in 
no transfer at all. Additionally, following a day five biopsy, 
embryos typically need to be cryopreserved and then 
thawed which precludes the transfer of a fresh embryo. 
While there are many methods of performing PGT, each 
method has its own benefits and limitations (Wang, et. al. 
2018). Once the cells are removed, they are genetically 
analyzed by either polymerase chain reaction (PCR), flu-
orescence in situ hybridization (FISH), array-comparative 
genomic hybridization, and more recently, next-genera-
tion sequencing, in order to determine if there are any 
genetic defects (Heijligers, et. al. 2018). 
Because PGT is an invasive procedure, researchers have 
wondered if it increases the risk of adverse clinical out-
comes. It is especially important to monitor the safety of 
PGT since the majority of the PGT couples, specifically 
couples undergoing PGT-M, have no fertility issues and have 
the alternative of a natural conception with or without in-
vasive prenatal testing. This review is aimed at determining 
whether PGT increases the risk of adverse obstetric and 
neonatal clinical outcomes as well as future development.
Methods
The research discussed in this paper was collected using 
EBSCO, ProQuest, PubMed and Google Scholar with ac-
cess provided by the Touro College Library. All articles 
included are original, peer reviewed research papers that 




A study was aimed at evaluating the safety of PGT and 
focused on the rate of congenital malformations as well 
as other adverse perinatal outcomes. In this study, embry-
os for PGT analysis were produced by intracytoplasmic 
sperm injection (ICSI) and subjected to blastomere biop-
sy. Parents filled out a questionnaire regarding their preg-
nancy and the health of their child. Medical information, 
such as age of both parents at embryo transfer, gravidi-
ty, parity, number of previous in vitro fertilization (IVF)/ 
PGT cycles, whether the embryo(s) was fresh or frozen/ 
thawed, how many blastomeres had been removed, and 
how many embryos were transferred, was also obtained 
from their doctor. The largest proportion of couples in 
this study opted for PGT-M, in order to avoid passing an 
autosomal dominant disease to the child. In this study, 
more girls than boys were born after PGT with a ratio 
of 1.2. This may be due to sex-selection, where a female 
embryo is transferred to reduce the risk of inheriting an 
X-linked condition. Major congenital malformations were 
found in nine of the 364 live births (2.5%). Four of these 
children had multiple congenital anomalies and five chil-
dren (1.4%) had minor malformations. Three pregnancies 
were terminated because of diagnoses of exencephaly, 
trisomy 18, and trisomy 21. The major malformation rate 
when including pregnancy terminations due to congen-
ital malformations was 3.3%. A report by the European 
Surveillance of Congenital Anomalies stated a prevalence 
of 261.45 major and minor birth anomalies per 10,000 
births (2.6%) between 2008 and 2012, which is similar 
to the rate in this study. According to these results, the 
risk of major malformations in children born after PGT 
does not seem to be increased when compared to the 
general population. The study also found that perinatal 
deaths were reported in 3 out of 364 PGT pregnancies 
studied. Two of the pregnancies were of a twin and a trip-
let. Additionally, at 37 weeks gestational age, a singleton 
was stillborn, after an uncomplicated pregnancy. With a 
perinatal mortality rate of 0.8%, no evidence for a poten-
tial increased risk in fetal or neonatal death was found 
after PGT (Heijligers, et. al. 2018).
Similar results were found in a study that looked at the 
health of 49 children conceived after PGT compared to 
66 naturally conceived (NC) controls. Control children 
were matched for age, sex, ethnicity, maternal educational 
level and socioeconomic status. A majority of PGT sub-
jects had undergone PGT-A, however the study did not 
distinguish between subjects who had undergone PGT-
M, PGT-A, or PGT-SR. However, all PGT subjects were 
born after an embryo biopsy at the eight to ten cell stage. 
Pediatricians that assessed the children were blinded to 
the conception status of the children, strengthening the 
results of this study. The study found that two children 
born after PGT had congenital anomalies, one with a 
minor ear deformity and the other with mild hypospadias 
(Banerjee, et. al. 2008).
Another study examined whether PGT blastomere bi-
opsies impacted the health of infants up to two months of 
age by comparing the data of 995 children born after PGT 
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and 1507 children born after IVF and ICSI. Twenty-three 
PGT children (2.3%) and 40 ICSI children (2.7%) present-
ed major malformations. Major genital malformations 
were recorded in seven PGT children and 9 ICSI children. 
Four stillborns conceived after PGT and seven stillborns 
conceived after ICSI presented major malformations. The 
total major malformation rate, including stillborn and live 
born, was comparable in the PGT group (2.6%) and the 
ICSI group (3%). These results do not indicate that the 
added cleavage-stage biopsy procedure increases the risk 
of major birth defects compared to the ICSI procedure 
(Desmyttere, et. al. 2012).  
In another study, data from the PGT pregnancies of 158 
singletons, 42 pairs of twins, and 1 set of triplets was com-
pared to data obtained from 242 children born after IVF/ 
ICSI and 733 randomly selected NC children born during 
the same time period. The mothers in all groups were 
matched for age, preconception body mass index, and pari-
ty.  Data collected included parental demographic informa-
tion, type of biopsy performed (polar body and/ or blas-
tomere biopsy), number of embryos transferred, whether 
the embryo(s) were fresh or frozen/ thawed, gestational 
age and mode of delivery. At two to four months, parents 
also filled out a questionnaire regarding any malformations 
that had not been diagnosed at birth. In both single and 
multiple pregnancies, the type of embryo biopsy had no 
significant influence the neonatal outcome. Four of the 
PGT children (1.7%) presented congenital malformations. 
One intrauterine fetal death occurred at 33 weeks with a 
subsequent diagnosis of thrombophilia. The congenital mal-
formation rate for PGT pregnancies is similar to the rates 
found in other studies (Eldar-Geva, et. al. 2014). Additionally, 
in another Israeli study completed around the same time 
of 213,288 NC births, the rate of congenital malformations 
was 1.9% which is similar to the rate of malformation after 
PGT in this study (Farhi, et. al. 2013).
Another study looked at the health of 581 children 
born after a blastomere biopsy. Questionnaires were sent 
to both physicians and parents at conception and deliv-
ery and children were examined at two months of age, 
usually by a clinical geneticist. The researchers followed 
484 pregnancies, with three terminations for major mal-
formations seen on prenatal ultrasounds. Of these, 385 
were singleton pregnancies, 92 were twin pregnancies 
and four were triplet pregnancies leading to a total of 
581 PGT children. There were no differences in any of 
the studied properties between biopsies done for PGT-M 
or PGT-A and the results were therefore combined. As 
seen in many other studies, sex distribution of live born 
children was uneven with 54% girls for 46% boys and is 
due to sex selection for X-linked diseases. Of the 581 
children in the PGT cohort, eighteen were stillborn and 
nine died neonatally.  Of these 27 perinatal deaths, four 
were in singleton pregnancies and 23 in multiple pregnan-
cies. The rate of perinatal deaths in singletons is compa-
rable to the ICSI cohort, however the ICSI multiple birth 
cohort had a higher perinatal death rate. Major malfor-
mations were seen in 17 PGT fetuses which led three to 
be terminated. This led to a malformation rate in born 
and unborn children of 2.9%. Of the fourteen children 
with malformations, two were stillborn and both were 
from a multiple pregnancy. This leaves one inherited and 
eleven sporadic mutations in the 563 PGT children born 
alive with a rate of 2.13%. The major malformation rate 
in the ICSI cohort was 3.13%. The main finding of this 
study is that a day three embryo biopsy does not seem 
to increase the risk of major malformations. When these 
results are compared with the data collected from IVF/ 
ICSI children born within the same timeframe, the rate of 
malformations is comparable. (Liebaers, et. al. 2010)
Gestational Age/ Birth Weight
Studies also looked at the gestational age and birthweight 
of children conceived through PGT. In the study by 
Heijligers et al. (2018), eighty percent of the PGT children 
were born full term. Eight children, all from twin preg-
nancies (2.2%), were born very premature (<32 weeks). 
The study distinguished very premature children from 
premature children to show that the very premature 
children were all from twin pregnancies. Less than 15% of 
the PGT children had a low birth weight and were either 
twins or triplets. Only one singleton had a very low birth 
weight. The child was born at 35 weeks through caesari-
an section because of HELLP syndrome in the mother. A 
z-score of + 0.17 was calculated for the singletons which 
indicates a comparable birth weight between this cohort 
and the rest of the Dutch population. In concordance 
with other studies on PGT there is an evident increase in 
prematurity and low and very low birth weight in multi-
ples when compared to singletons. This strongly supports 
the current Dutch single embryo transfer policy. Overall, 
data from this study on pregnancy duration and birth 
weight in the Dutch PGT population, especially in the sin-
gletons, seems similar to the published data on naturally 
conceived children.
In the study performed by Eldar-Geva et. al. (2014), 
the difference in mean birth weight for singleton preg-
nancies between the three groups was statistically sig-
nificant. Singleton NC children had a significantly higher 
birth weight than those born after ICSI (P=.006) but not 
compared to the PGT singletons. Low birth weight was 
also more frequent in the ICSI group than in the PGT and 
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NC singletons. Also, significantly more ICSI twins (58%) 
presented with low birth weight compared to 41.0% of 
PGT twins and 44.2% of NC twins.  Very low birth weight 
(<1,500 g) was rare in all groups. There was also a sta-
tistically significant difference among the groups when 
examining intrauterine growth for singleton pregnancies 
(P=.001). Intrauterine growth restriction was more fre-
quent in ICSI pregnancies (9.5%) than in NC (5.5%) or 
PGT pregnancies (5.1%). Children born large for their 
gestational age was more frequent in the PGT group 
(16.5%) than the NC group (8.8%). The mean gestational 
age, rates of preterm birth and intrauterine growth re-
striction for twin and triplet pregnancies were similar for 
the three groups.  
 These results show that there are no increased risks of 
intrauterine growth restriction or low birth weight in sin-
gleton or twin pregnancies after PGT compared to NC. 
However, ICSI pregnancies did show an increased risk for 
both of these complications. These results remained true 
even after controlling for factors such as maternal age, 
parity, BMI, number of embryos transferred and whether 
the embryo was cryopreserved, which can affect preg-
nancy outcomes. The increased likelihood of adverse 
outcomes in ICSI pregnancies may be due to the fertility 
status of the parents. Infertile women are more prone 
to adverse outcomes even when conceiving naturally, in-
dicating that infertility itself is what increases the risk of 
adverse outcomes such as low birth weight and preterm 
delivery (Basso, Baird, 2003). This may explain the similar-
ity of the results in birth weight and intrauterine growth 
from PGT and NC pregnancies, since the majority of PGT 
couples usually do not struggle with fertility. 
The difference in pregnancy duration for singleton 
pregnancies between the three cohorts was also statis-
tically significant. NC pregnancies were longer, than both 
the PGT and the ICSI pregnancies. However, for the PGT 
group, these findings had no clinical significance because 
the frequency of preterm deliveries, both <37 (7.4%) and 
<34 weeks (1.3%) was comparable with NC pregnancies 
(5.7% and 2.0%, respectively). However, 11.4% of the ICSI 
cohort were born prematurely. PGT and ICSI pregnancies 
may have been shorter for different reasons. Women who 
undergo PGT are at high risk for autosomal recessive, 
X-linked, or dominant genetic disease and therefore have 
a higher incidence of previous pregnancy terminations for 
affected fetuses. Complications associated with induced 
abortions include premature delivery of future children 
and cervical incompetence. Additionally, some of the PGT 
women in the study had autosomal dominant diseases 
such as myotonic dystrophy, achondroplasia, neurofibro-
matosis and tuberous sclerosis and because of this chose 
to have a cesarean delivery at 37 to 38 weeks. In fact, 
the PGT cesarean delivery rate was more than double in 
PGT pregnancies. Additionally, some of the families had 
critically ill children which may have placed an emotional 
and physical burden on the family and pregnant mother 
(Eldar-Geva, et. al. 2014).  The preterm birth rate for the 
IVF/ ICSI group is unsurprising. As discussed above many 
studies have found that preterm birth is associated with 
children conceived through IVF/ ICSI because of the par-
ents underlying fertility issues (Wisborg, et. al. 2010). 
Another study looked at the health of 49 PGT children 
and 66 NC children. The PGT cohort had a significant-
ly lower gestational age at birth (P = 0.0001) and more 
preterm births than the NC group. The PGT group was 
also more likely to have a lower birth weight and a higher 
number of births with a birth weight of less than 2500 
grams. Interestingly, this finding is consistent with other 
studies of assisted reproduction outcomes such as IVF/ 
ICSI. In most cases PGT conception is closest to natu-
ral conception and not assisted reproduction concep-
tion, with regard to the reproductive health of parents. 
Parents who opt to undergo the most common form of 
PGT, PGT-M, usually do not have fertility issues but are 
concerned with passing a genetic disease to their chil-
dren. However, in this study, the majority of PGT patients 
had undergone PGT-A in which parents bear closer risk 
and resemblance to couples undergoing other assisted 
reproductive conception. PGT-A is usually used after 
failed IVF cycles or because of other fertility issues, such 
as advanced maternal age. It is therefore unsurprising that 
the age of the PGT mothers was significantly higher than 
the NC mothers, (P = 0.0001)  as was the rate of preterm 
birth and low birth weight in the PGT group, which is 
commonly seen in other assisted reproduction outcome 
studies (Banrjee, et. al. 2008). 
The study performed by Desmyttere et. al. (2012), 
found that the average birthweight for PGT singletons 
and PGT multiples with a very low birth weight (<1500 g) 
was comparable with the ICSI children. However, signifi-
cantly more ICSI multiples presented a low birthweight 
(<2500 g), more specifically 268 (17.8%) ICSI compared 
to 161 (16.2%) PGT babies. Again, this may be due to the 
fertility status of the parents, since the ratio of infertile 
couples was higher in the ICSI cohort than in the PGT 
cohort. Measurements of height and head circumfer-
ence showed no significant differences between the two 
groups.  Mean gestational age at birth for PGT singletons, 
twins and triplets showed no difference compared to the 
ICSI group. Additionally, the number of PGT singletons 
and multiples born prematurely (<37 weeks) showed 
no differences compared with their ICSI counterparts 
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(all P-values > 0.05). Twenty-one ICSI and four PGT sin-
gletons versus 67 ICSI and 31 PGT multiples were born 
very prematurely (<32 weeks) which is not significant 
(P = 0.056 and P = 0.43 for singletons and multiples). 
Admission after delivery to the neonatal intensive care 
unit was comparable for both the PGT and ICSI groups 
for singletons and multiples. These results show that sin-
gletons and multiples born after a PGT embryo biopsy 
had similar neonatal outcomes in terms of auxological 
data, gestational age and neonatal hospital admission, to 
the control group of singletons and multiples with no 
embryo biopsy. Additionally, in this study, PGT multiples 
appear to be at a lower risk for low birthweight when 
compared to IVF/ ICSI multiples. 
The study by Liebaers et al. (2010) found that in the 
PGT cohort, 11.5% of singletons and 65.7% of multiples 
were born premature. In the ICSI cohort, 8.4% of single-
tons and 57.9% of multiples were born premature. Low 
birthweight was observed in 7.4% of PGT singletons and 
very low birth weight in 3 (0.8%) PGT children. Multiple 
PGT births of a low birth weight (62.5%) were signifi-
cantly lower than ICSI multiple births (49.4%).  Very low 
birth weight was observed in 19 of the PGT multiples. 
These results suggest that a three day PGT biopsy does 
not seem to add significant health risks for singleton PGT 
children since when these results were compared to the 
data collected from IVF/ ICSI children born within the 
same years, gestational ages and birthweights were similar. 
However, PGT multiples appeared to be at an increased 
risk of low birthweight, preterm birth, and perinatal death 
compared to ICSI multiples. Multiple pregnancies should 
be avoided when possible and may potentially solve prob-
lems especially regarding perinatal death.
A similar study looked at whether women who con-
ceived after PGT and their children have greater risks of 
adverse pregnancy and birth outcomes compared with 
children conceived spontaneously or after IVF with or 
without intracytoplasmic sperm injection (ICSI). The study 
looked at factors such as pre-eclampsia, preterm prima-
ry rupture of membranes, placenta previa, abruption of 
placenta, preterm birth, low birth weight, major malfor-
mations, and neonatal admission. It was found that com-
pared to women conceiving spontaneously, women who 
had undergone PGT or IVF/ ICSI were older, more often 
uniparous, had a higher BMI and smoked less often during 
pregnancy. The children conceived after IVF/ ICSI had a 
lower birth weight, shorter gestational age, longer neonatal 
hospital admission and an increased risk of preterm birth 
and malformations. Children born after PGT had a compa-
rable risk of the same complications, however, the results 
were just short of statistical significance for many of the 
outcomes. Nonetheless, PGT children were found to have 
a significant increased risk of preterm birth, shorter ges-
tation, and longer neonatal hospital admission. The study 
also looked at the difference in outcomes between PGT-
M, PGT-A and PGT-SR. When compared to NC children, 
PGT-SR and PGT-A children did not have an increased risk 
of adverse neonatal outcomes. When compared to IVF/ 
ICSI children, PGT-SR and PGT-A children had comparable 
neonatal outcomes and were found to have a higher mean 
birth weight.  However, compared to NC children, children 
born after PGT-M had a significantly lower birth weight, 
shorter gestation and increased risk for longer neonatal 
hospital admission. These results show an increased risk 
of neonatal complications in PGT pregnancies when com-
pared to spontaneous pregnancies. However, the risk of 
adverse outcomes was generally comparable to IVF/ ICSI 
pregnancies, indicating that the actual embryo biopsy does 
not add additional risks. Additionally, when separating 
PGT-SR and PGT-A pregnancies from PGT-M pregnancies, 
adverse neonatal outcomes were only found in children 
conceived through PGT due to a parental monogenetic 
disorder (PGT-M) and not in children born after PGT-SR 
and PGT-A. These results make it likely that the risk of ad-
verse outcomes is not related to PGT itself, but to the un-
derlying condition of the parents. These factors can include 
the known genetic disorder, associated comorbidities or 
any medications taken during pregnancy. (Bay, et. al. 2016)
A study compared the growth data at birth and two 
years for 70 singletons born after PGT, ICSI or natural 
conception. Children were matched for gender, language, 
birth order and maternal education level. At birth, height 
and head circumference data were comparable for the 
PGT, IVF/ ICSI and NC cohorts. While the PGT singletons 
tended to have a lower birthweight and gestational age 
compared with the NC children, these differences did not 
reach statistical significance. When comparing children 
born after a biopsy of one or two blastomeres, weight, 
height and head circumference measurements were 
comparable for the two groups. Additionally, admission 
to a neonatal ward was comparable in the three concep-
tion groups and PGT children did not experience more 
hospital stays for medical reasons than the ICSI and NC 
groups. PGT children were also reported to have under-
gone more complementary examinations (with normal 
results) compared with NC and ICSI babies. However, 
this is probably due to precautionary measures for ‘spe-
cially conceived’ children (Desmyttere, et. al. 2009).
Obstetric Outcomes
In the study performed by Eldar-Geva et. al. (2014), the in-
cidence of pregnancy complications such as hypertension 
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and diabetes were similar in the PGT, IVF/ ICSI and NC 
groups. Of the PGT mothers 1% had hypertension and 
2% had gestational diabetes. Of the ICSI and NC moth-
ers, 1% had hypertension and 6% had diabetes, and 3% 
had hypertension and 4% had diabetes, respectively. 
Additionally, the differences in mode of delivery for sin-
gleton pregnancies was statistically significant. The cesar-
ean delivery rates were 28.5% in the PGT group, 31.6% in 
the ICSI group, and 11.0% in the NC group (P<.005). As 
discussed earlier, the cesarean rate for the PGT cohort 
was more than double the rate of the NC group in this 
study and was probably due to the fact that women with 
autosomal dominant diseases in the PGT cohort opted 
to have a cesarean delivery at 37 to 38 weeks.
In the study performed by Desmyttere et. al. (2009), 
increased rates of cesarean births were found when PGT 
mothers were compared to IVF/ ICSI mothers. Results 
also showed that when compared to NC mothers, PGT 
mothers experienced more pregnancy complications 
such as gestational diabetes, thyroid pathology, pregnan-
cy-induced hypertension, placental pathology and prema-
ture contractions. However, there were no differences 
regarding pregnancy complications when comparing PGT 
and IVF/ ICSI mothers.
In the study performed by Bay et. al. (2016) the IVF/ 
ICSI cohort showed an increased risk of placental dis-
orders, including placenta previa, pre-eclampsia, placental 
abruption, preterm primary rupture of membranes, and 
induction of labor or cesarean section. The women who 
gave birth after PGT had a comparable risk for most of 
the same complications when compared to the NC co-
hort, although for most of the outcomes the results were 
just short of statistical significance. However, the PGT 
cohort did show a significant increased risk of placenta 
previa and cesarean section. Because the risk of adverse 
outcomes was generally comparable to IVF/ ICSI preg-
nancies in many of these studies, it seems like the actual 
embryo biopsy does not add additional risks. 
When the study separated PGT-M subjects from PGT-A 
and PGT-SR subjects interesting results emerged. PGT-SR 
and PGT-A children did not have an increased risk of any 
adverse obstetric outcomes, except for a higher risk of 
placenta previa when compared to NC controls. When 
compared to IVF/ ICSI children, PGT-SR and PGT-A chil-
dren had comparable obstetric outcomes.  However, 
compared to NC children, children born after PGT-M 
had a significantly increased risk for preterm primary 
rupture of membranes, cesarean section and placenta 
previa. Again, these results make it likely that the risk of 
adverse outcomes is not related to PGT itself, but to the 
underlying condition of the parents. However, there was 
a consistent increased risk of placenta previa after both 
PGT and IVF/ICSI, which suggests that parental factors do 
not explain all the adverse outcomes. 
Follow up Study 
Growth
A study assessed whether PGT causes adverse outcomes 
by comparing findings at birth and at 2 years of age for 
singletons born after PGT, IVF/ ICSI, and NC. The study 
also investigated whether the body size of children born 
after biopsy of one blastomere was different from that of 
children born after biopsy of two blastomeres. Subjects 
in all groups were matched for gender, maternal educa-
tional level, mother tongue and birth order.  A strength to 
this study is that all children were examined by the same 
pediatrician in a standardized way. At a two year follow 
up, weight, height, head circumference, and waist and arm 
measurements were comparable for the three cohorts. 
These results show that PGT singletons do not appear 
to be at a higher risk of growth retardation compared 
with IVF/ ICSI and NC singletons. In PGT children, the 
mean BMI was statistically significantly lower compared 
with NC children. Growth parameters of the PGT chil-
dren born after biopsy of one blastomere were compa-
rable to children born after a biopsy of two blastomeres. 
(Desmyttere, et. al. 2009) 
The study performed by Banerjee et. al. (2008) found sim-
ilar results. When assessed at the mean age of 18 months, 
growth parameters for all PGT children were within the 
normal range including the children who had been born 
preterm and/ or with a low birthweight. Furthermore, 
Desmyttere et. al. (2009) found that in their follow up study 
that rates of chronic disease and chronic use of medication 
were similar between PGT and NC children. 
Socio-emotional and Language Development
A study was performed to assess the socio-emotional 
and language development of children at age two born 
after PGT, IVF/ ICSI, and NC, as well as parental wellbe-
ing. A small number of children (n= 10) that were born 
before between 33-36 weeks gestations were included 
in the study and were equally distributed among the co-
horts. Most of these children had a normal birth weight 
(<2500 g), and none of them had a very low birth weight 
or obtained an Apgar score of less than nine after ten 
minutes. Twins were excluded from the study because 
developmental outcome is affected by prematurity and 
low birth weight, which are known to be more com-
mon in twins and triplets. NC and ICSI controls were 
matched for gender, maternal education level, native lan-
guage, and birth order. All members of the PGT cohort 
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had a blastomere biopsy at the eight-cell stage. Parents 
were asked to complete the Short Temperament Scale 
for Toddlers (STST) and the Child Behavioral Checklist 
(CBCL) in order to assess the child’s socio-emotional 
development. The STST, placed children into one of three 
temperament categories, easy, average or difficult. The 
CBCL answers questions about the child’s emotional and 
behavioral problems. Parents answered if the problem 
presented is ‘not true’, ‘somewhat or sometimes true’ or 
‘very true or often true’ of their child,  with item scores 
of 0, 1 or 2.  A total score of 60 is at the bottom of 
the clinical range, and a score of 64 or more represents 
larger issues. Language comprehension and production 
were rated according to the McArthur Communicative 
Developmental Inventories.
The CBCL scores showed no difference in the pro-
portion of children above the clinical threshold points 
according to mothers and fathers.  After controlling for 
socio-demographic variables, PGT and ICSI mothers 
reported significantly fewer problems than the NC co-
hort. According to the STST scores, a similar proportion 
of parents from all three conception groups reported 
their child’s temperament as easy, average or difficult. 
This remained true even after controlling for socio-de-
mographic variables.  Additionally, the mean Language 
Comprehension score and Language Production score 
did not differ significantly among the cohorts.
This study had some weaknesses. Firstly, results were 
obtained exclusively from parental reports and more valid 
reports could have been obtained from a multiple infor-
mant approach. Additionally, the PGT cohort had members 
that had undergone PGT-M and PGT-A. Since these pro-
cedures are usually done for different reasons, PGT-M and 
PGT-A populations have different medical histories and 
family backgrounds, which may influence socio-emotional 
and language results (Nekkebroeck, et. al. 2008a). 
Additionally, the study by Banerjee et al. (2008) found 
that the PGT cohort had significantly higher scores on 
the Hearing and Language subscale, than the NC group. 
These studies suggest that PGT does not cause adverse 
neurodevelopmental outcomes.
Mental and Psychomotor Development
In the study by Banjeree et al. (2008), children up to age 
four were evaluated with a focus on neurodevelopmental 
screening which was measured using the Griffiths Scales 
of Mental Development. The mean Griffiths quotient for 
both the PGT and NC groups were in the normal range 
and did not differ significantly. The only significant differ-
ences were for the Locomotor subscale, where the PGT 
group was significantly lower than the NC group.
A similar study aimed at assessing the mental and psy-
chomotor developmental outcomes in two-year-old chil-
dren conceived through PGT compared to children born 
after IVF/ ICSI and natural conception (NC). ICSI and NC 
controls were matched for gender, maternal education, 
birth order, and native language. All PGT subjects had a 
blastomere biopsy at the eight-cell stage of the embryo. 
At two years of age, the children were all tested by a psy-
chologist using the Dutch version of the Bayley Scales of 
Infant Development (BSID). The psychologist was blinded 
to the status of the subject’s conception while conduct-
ing the evaluation. Parents were questioned regarding 
socio-demographic characteristics. The BSID consists 
of two major scales. The mental scale measures visual 
and auditory information procession, imitation, memory, 
hand-eye coordination, and problem solving. The motor 
scale appraises control of gross and fine motor skills.
There were no significant group differences regarding 
mental and motor scale scores. Additionally, equal numbers 
of PGT, ICSI, and NC subjects were represented in each 
level (accelerated, normal, delayed) of psychomotor and 
mental development. Interestingly, when compared across 
all three cohorts, psychomotor and mental development 
scores were very similar for males and females. However, 
when compared within each cohort, ICSI boys obtained 
lower scores on both scales than the ICSI girls (P = 0.061). 
The mode of delivery had no impact on psychomotor or 
mental development even after controlling for sociodemo-
graphic factors. (Nekkebroeck, et. al. 2008b).
 From the results of these two studies, it can be con-
cluded that the embryo biopsy done in PGT has no im-
pact on the mental and psychomotor development of 
two-year-old children, compared to ICSI and NC children
Parent-Child Relationship
The study by Banerjee et. al. (2008), used the Parental 
Stress Index and the Parental Acceptance-Rejection 
Questionnaire to assess differences in the parent-child 
relationship. The Parental Stress Index, which asked par-
ents about parental distress, parent–child dysfunctional 
interaction, and the difficulty of the child, showed no 
significant difference between the PGT and NC groups. 
In the Parental Acceptance-Rejection Questionnaire, 
the PGT group had significantly higher scores on the 
warmth-affection subscale, and significantly lower scores 
on the aggression-hostility and rejection subscales than 
the NC group. 
In another study parental stress and health status were 
measured with the Parent Stress Index and the General 
Health Questionnaire (GHQ). No differences in parental 
stress were found for mothers and fathers among the 
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three groups. However, after controlling for socio-demo-
graphic variables, the ICSI mothers and fathers reported 
less stress from parenting (P = 0.048). These results are 
similar to findings in other studies and may be because 
greater efforts are made by ICSI parents to have a child 
compared to parents who conceive naturally.  Another 
theory is that ICSI parents may be inclined to underre-
port behavioral issues because of their need to demon-
strate their abilities as parents and move on from the 
issue of infertility where they struggled. On the other 
hand, there was an equal proportion from all three co-
horts that experienced low, moderate or high levels of 
parenting stress. Scores on the GHQ measuring parental 
health were not significantly different, even after con-
trolling for socio-demographic factors. Parents from all 
three conception groups obtained similar scores on the 
subscales: somatic symptoms, anxiety, social dysfunction 
and severe depression. The results from these studies 
imply that parents seem to cope with the extra stress 
of PGT without it affecting the parent-child relationship 
(Nekkebroeck, et. al.  2008a). 
Conclusion
Overall, it does not seem that preimplantation genetic 
testing causes adverse clinical outcomes. This is especial-
ly important since the majority of couples who undergo 
PGT usually do not have fertility issues and have the op-
tion of natural conception with invasive prenatal testing. 
The results of these research studies show no significant 
increased risk of perinatal death or malformations, espe-
cially when compared to IVF/ ICSI births, indicating that 
the embryo is able to recover from the cells removed 
during the biopsy and it therefore adds no additional risk. 
Furthermore, children conceived through PGT seem to 
be on the same developmental level as their peers and 
show no growth retardation in follow up studies. While 
some studies show an increased risk of preterm delivery, 
low birth weight and some obstetric outcomes, it is im-
portant to determine whether this is because of the em-
bryo biopsy or because of the underlying health condition 
of the parents such as the fertility issues or the genetic 
disease for which they chose to undergo PGT in the first 
place. However, since this technology is fairly new, there 
are few follow up studies that investigate the long-term 
effects of PGT. Additional follow up studies are necessary 
to ensure the long-term safety of this technology. Future 
studies can also investigate the specific outcomes for 
each method of PGT, since most of the research is either 
regarding a blastomere biopsy or combines all methods 
of PGT in the PGT cohort. Furthermore, future studies 
should focus on determining the outcome differences 
between PGT-M, PGT-A and PGT-SR since parents who 
undergo the different forms of PGT have different med-
ical backgrounds which can affect the results of these 
studies. Couples considering PGT should consult their 
physician or a genetic counselor to determine whether 
PGT is the correct option as well as which method of 
PGT should be used.
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